We are live on ! Find out more
E

Entelevest Portfolio holdings

AUM $117M
This Fund
S&P 500
This Quarter Est. Return
+20.75%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
+$17.1M
Cap. Flow
+$4.24M
Cap. Flow %
3.62%
Top 10 Hldgs %
42.93%
Holding
157
New
20
Increased
76
Reduced
35
Closed
15
Avg Time Held Equity + Options
1.6 quarters
Top 10 Avg Time Held Equity + Options
1.7 quarters
Top 20 Avg Time Held Equity + Options
1.8 quarters
Avg Time Held Equity only
1.7 quarters
Top 10 Avg Time Held Equity only
1.7 quarters
Top 20 Avg Time Held Equity only
1.8 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 73.79%
2 Technology 12.03%
3 Consumer Discretionary 3.11%
4 Communication Services 3.02%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
JNJ icon
151
CALL
Johnson & Johnson
JNJ
$630B
– –
-100
Closed -$24.4K –
LHX icon
152
L3Harris
LHX
$44.1B
– –
-614
Closed -$212K –
SAP icon
153
CALL
SAP
SAP
$248B
– –
-100
Closed -$17.1K –
SAP icon
154
SAP
SAP
$248B
– –
-1,362
Closed -$233K –
XLF icon
155
CALL
State Street Financial Select Sector SPDR ETF
XLF
$51.2B
– –
-1,000
Closed -$49.4K –
XLV icon
156
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
– –
-500
Closed -$73.3K –
XOM icon
157
ExxonMobil
XOM
$695B
– –
-2,851
Closed -$484K –

Similar funds

Entelevest's Q2 2026 Portfolio in Review

As of Q2 2026, Entelevest held 157 positions worth $117M, up 17% from $100M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Entelevest deployed $4.24M of net new capital in Q2 2026, opening 20 new positions and adding to 76 existing holdings. Its largest new stake was Novartis: 1,810 shares worth $284K.

By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Micron Technology, an estimated $526K trimmed.

  • Entelevest's largest Q2 2026 buy was Novartis: 1,810 shares worth $284K.
  • Entelevest added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $311K increase.
  • Entelevest's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $526K.
  • Entelevest fully exited ExxonMobil in Q2 2026, selling an estimated $484K.
  • Entelevest's ten largest holdings make up 43% of its $117M portfolio in Q2 2026.
  • Entelevest opened 20 new positions and closed 15 in Q2 2026.
  • Entelevest's portfolio value rose 17% quarter-over-quarter to $117M.

Based on Entelevest's 13F filing for Q2 2026, filed 22 Jul 2026.